A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on 20 December 2019 |
| Author/s |
author: Ashkan Emadi Christopher Lescinskas Timothy A. Graubert Rupa Narayan Amir T Fathi |
| Publication date | December 20, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |